Tenormin and Equanil drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Tenormin (atenolol) and Equanil (meprobamate). Common drug interactions include vasculitis among females and pyrexia among males.

The phase IV clinical study analyzes what interactions people have when they take Tenormin and Equanil. It is created by eHealthMe based on reports of 23 people who take the same drugs from the FDA, and is updated regularly.

What is Tenormin?

Tenormin has active ingredients of atenolol. It is often used in high blood pressure. eHealthMe is studying from 20,474 Tenormin users. Check the latest studies of Tenormin.

What is Equanil?

Equanil has active ingredients of meprobamate. It is often used in stress and anxiety. eHealthMe is studying from 1,244 Equanil users. Check the latest studies of Equanil.



On Jul, 18, 2026

23 people who take Tenormin and Equanil together, and have interactions are studied.

Tenormin and Equanil drug interactions.

What are the common drug interactions of Tenormin and Equanil, by gender? *:

female:

  1. Vasculitis (inflammation of a blood vessel or blood vessels)
  2. Hyponatraemia (abnormally low level of sodium in the blood; associated with dehydration)
  3. Overdose
  4. Renal failure (kidney dysfunction)

male:

  1. Pyrexia (fever)
  2. Eosinophilia (eosinophil count in the peripheral blood exceeds)
  3. Haematuria present (presence of blood in urine due to trauma)
  4. Pneumonitis aspiration (acute lung injury after the inhalation of regurgitated gastric contents)
  5. Pyelonephritis acute (sudden inflammation of kidney caused by bacteria)
  6. Rash erythematous (redness of the skin)
  7. Serotonin syndrome (occurs when two drugs that affect the body's level of serotonin are taken together at the same time)
  8. Transient ischaemic attack (a transient episode of neurologic dysfunction caused by ischemia (loss of blood flow))
  9. Urinary tract infection
  10. Biliary tract disorder

What are the common drug interactions of Tenormin and Equanil, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Coma (state of unconsciousness lasting more than six hours)
  2. Cystitis (inflammation of the wall of the bladder)
  3. Drug toxicity
  4. Haematuria present (presence of blood in urine due to trauma)
  5. Pneumonitis aspiration (acute lung injury after the inhalation of regurgitated gastric contents)
  6. Pyelonephritis acute (sudden inflammation of kidney caused by bacteria)
  7. Pyrexia (fever)
  8. Urinary tract infection
  9. Culture urine positive
  10. Cystitis escherichia (inflammation of the wall of the bladder by bacteria escherichia coli)

50-59:

  1. Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets)

60+:

  1. Pyrexia (fever)
  2. Vasculitis (inflammation of a blood vessel or blood vessels)
  3. Serotonin syndrome (occurs when two drugs that affect the body's level of serotonin are taken together at the same time)
  4. Transient ischaemic attack (a transient episode of neurologic dysfunction caused by ischemia (loss of blood flow))
  5. Biliary tract disorder
  6. Blood creatine phosphokinase increased
  7. Cholestasis (a condition where bile cannot flow from the liver to the duodenum)
  8. Coma hepatic (accumulation in the bloodstream of toxic substances that are normally removed by the liver leads coma)
  9. Cytolytic hepatitis (dissolution or destruction of a liver cell)
  10. Hyponatraemia (abnormally low level of sodium in the blood; associated with dehydration)

What are the existing conditions these people have? *

  1. Urinary Tract Infection: 6 people, 26.09%
  2. Sleep Disorder: 5 people, 21.74%
  3. Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 5 people, 21.74%
  4. Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 5 people, 21.74%
  5. Hyperlipidaemia (presence of excess lipids in the blood): 5 people, 21.74%
  6. Gastrointestinal Disorder (functional problems of gastrointestinal tract): 5 people, 21.74%
  7. Diabetes: 5 people, 21.74%
  8. Nausea (feeling of having an urge to vomit): 4 people, 17.39%
  9. Indigestion: 4 people, 17.39%
  10. Aggression: 4 people, 17.39%

* Approximation only. Some reports may have incomplete information.

Do you take Tenormin and Equanil?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Tenormin and Equanil:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Tenormin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Equanil:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Tenormin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Equanil and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on atenolol and meprobamate (the active ingredients of Tenormin and Equanil, respectively), and Tenormin and Equanil (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: